tiprankstipranks
IGM Biosciences Inc (IGMS)
NASDAQ:IGMS
Holding IGMS?
Track your performance easily

IGM Biosciences (IGMS) Financial Statements

309 Followers

IGM Biosciences Financial Overview

IGM Biosciences's market cap is currently ―. The company's EPS TTM is $-3.648; its P/E ratio is -2.61; IGM Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 497.00K$ 651.00K$ 509.00K
Gross Profit-----
EBIT$ -61.43M$ -47.90M$ -53.86M$ -65.12M$ -66.76M
EBITDA$ -59.12M$ -43.36M$ -51.68M$ -62.94M$ -64.50M
Net Income Common Stockholders$ -61.43M$ -47.90M$ -49.82M$ -60.70M$ -61.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 218.79M$ 256.38M$ 293.77M$ 337.68M$ 386.99M
Total Assets$ 304.51M$ 336.50M$ 376.13M$ 423.41M$ 474.35M
Total Debt$ 45.86M$ 39.37M$ 40.93M$ 40.51M$ 41.19M
Net Debt$ -172.93M$ -217.01M$ -252.84M$ -297.17M$ -345.80M
Total Liabilities$ 225.56M$ 214.14M$ 214.88M$ 220.18M$ 220.49M
Stockholders Equity$ 78.95M$ 122.36M$ 161.00M$ 203.23M$ 253.86M
Cash Flow-
Free Cash Flow$ -39.67M$ -38.56M$ -44.90M$ -49.46M$ -43.20M
Operating Cash Flow$ -38.38M$ -37.37M$ -42.42M$ -48.01M$ -40.12M
Investing Cash Flow$ 12.99M$ 24.52M$ 8.65M$ -14.69M$ 19.55M
Financing Cash Flow$ 1.20M$ 615.00K$ 152.00K$ 402.00K$ 44.64M
Currency in USD

IGM Biosciences Earnings and Revenue History

IGM Biosciences Debt to Assets

IGM Biosciences Cash Flow

IGM Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis